 |
|
|
| |
Long-term clinical outcomes following SARS-CoV-2
infection include persistent symptoms and cardiovascular
disease beyond 3 months post-infection
|
| |
| |
IDWeek 2021 Sept 29-Oct 3
Download the PDF here
Brian K. Agan, MD
Deputy Science Director, HJF
Associate Professor
Infectious Disease Clinical Research Program, Department of Preventive Medicine &
Biostatistics Uniformed Services University of the Health Sciences
|
| |
|
|
|
|
|
